| Literature DB >> 16431844 |
Ishtiaq Ahmad1, Daniel C Hoessli, Evelyne Walker-Nasir, Saleem M Rafik, Abdul R Shakoori.
Abstract
Phosphorylation and O-GlcNAc modification often induce conformational changes and allow the protein to specifically interact with other proteins. Interplay of phosphorylation and O-GlcNAc modification at the same conserved site may result in the protein undergoing functional switches. We describe that at conserved Ser/Thr residues of human Oct-2, alternative phosphorylation and O-GlcNAc modification (Yin Yang sites) can be predicted by the YinOYang1.2 method. We propose here that alternative phosphorylation and O-GlcNAc modification at Ser191 in the N-terminal region, Ser271 and 274 in the linker region of two POU sub-domains and Thr301 and Ser323 in the POUh subdomain are involved in the differential binding behavior of Oct-2 to the octamer DNA motif. This implies that phosphorylation or O-GlcNAc modification of the same amino acid may result in a different binding capacity of the modified protein. In the C-terminal domain, Ser371, 389 and 394 are additional Yin Yang sites that could be involved in the modulation of Oct-2 binding properties.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16431844 PMCID: PMC1326018 DOI: 10.1093/nar/gkj401
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Percentage accuracy of prediction methods
| S. no. | Prediction methods | Percentage accuracy | ||
|---|---|---|---|---|
| Glycosylated/phosphorylated (%) | Non-glycosylated/non-phosphorylated (%) | Overall (%) | ||
| 01 | NetNGlyc1.0 | 86 | 61 | 76.50 |
| 02 | NetOGlyc 2.0 | 83 | 90 | 86.50 |
| 03 | DictyoGlyc1.1 | 97 | 97 | 97 |
| 04 | YinOYang1.2 | 72.50 | 79.50 | 76 |
| 05 | NetPhos2.0 | 69 | 96 | 82.50 |
Different Oct-2 proteins used for multiple alignment
| S. no. | Species | Database | Sequence ID/accession no. | Blast results | |
|---|---|---|---|---|---|
| Bits score | |||||
| 01 | Homo sapiens | SWISSPROT | PO2F2_HUMAN, P09086 | 0.00 | 695 |
| 02 | Sus scrofa | SWISSPROT | PO2F2_PIG, Q29013 | 0.00 | 678 |
| 03 | GenBank | AAA40767.1 | 0.00 | 678 | |
| 04 | Mus musculus | SWISSPROT | PO2F2_MOUSE, Q00196 | 0.00 | 639 |
| 05 | Canis familaris | RefSeq | XP_541592 | 1 × 10−143 | 510 |
| 06 | Ictalurus punctatus | EMBL | CAA73199.1 | 1 × 10−111 | 405 |
| 07 | Drosophila melanogaster | SWISSPROT | PDM2_DROM, P31369 | 1 × 10−61 | 237 |
Figure 1Graphical representation of potential for O-GlcNAc modification in serine and threonine residues in the human Oct-2 sequence. Green vertical lines show the potential of S/T residues for O-GlcNAc modification and light blue horizontal wavy line shows threshold for modification potential.
Figure 2(a) Potential for phosphate modification at serine and threonine residues in the human Oct-2 sequence and (b) sites with potential for both O-GlcNAc and phosphate, the Yin Yang sites with red asterisk at top.
Figure 3Multiple alignments of five mammalian sequences (human, pig, dog, rat and mouse), one from fish (catfish) and one from Drosophila. The consensus sequence is highlighted by asterisk, conserved substitution by double dot and semiconserved substitution by single dot. Different sequences are ordered as in aligned results from CLUSTALW and the numbers in parenthesis show position of human Oct-2 sequence aligned with the others.
Conserved S/T residues with PTMs potential of human Oct-2 aligned with that of other animals
| S. no. | Residue | Conservation status | Modification potential | ||||
|---|---|---|---|---|---|---|---|
| Mam | Vert | Dros | Phosphate | Yin Yang sites | |||
| 01 | Ser49 | * | * | N | HP | HP | Pr |
| 02 | Ser52 | * | * | . | VHP | HP | Pr |
| 03 | Ser54 | * | * | * | VHP | VCT | FN |
| 04 | Ser59 | * | * | : | HP | VCT | FN |
| 05 | Ser68 | * | N | N | VHP | HP | Pr |
| 06 | Thr150 | * | . | * | VCT | HP | FN |
| 07 | Thr172 | * | DG | . | VHP | VCT | FN |
| 08 | Ser191 | * | * | . | VHP | VCT | FN |
| 09 | Ser271 | * | * | . | HP | HP | Pr |
| 10 | Ser274 | * | * | * | VHP | VCT | FN |
| 11 | Ser284 | * | * | . | VHP | VCT | FN |
| 12 | Thr301 | * | * | * | VHP | VCT | FN |
| 13 | Ser323 | * | * | * | VHP | VCT | FN |
| 14 | Ser371 | * | * | * | VHP | HP | Pr |
| 15 | Ser389 | * | * | DG | HP | VHP | Pr |
| 16 | Ser394 | * | * | : | VHP | VCT | FN |
| 17 | Thr435 | * | . | DG | HP | HP | Pr |
| 18 | Thr441 | * | N | DG | HP | HP | Pr |
| 19 | Ser448 | * | N | DG | HP | HP | Pr |
| 20 | Ser452 | * | N | DG | HP | HP | Pr |
*, Conserved residue; :, conserved substitution; ., semi-conserved substitution; N, non conserved substitution; DG, deletion gap; VHP, very high potential; HP, high potential; VCT, very close to threshold; Pr, predicted by YinOYang 1.1; F.N, false negative; Mam, mammals; Vert, vertebrates; Dros, drosophila.
Note: only those S/T residues are listed in the table which are potential Yin Yang sites and conserved as well. The proposed Yin Yang sites are highlighted by bold face.
Possible Yin Yang sites in different domains of human Oct-2
| S. no. | Domain/region | Yin Yang sites predicted by YinOYang1.2 | Yin Yang sites proposed on the basis of false negative |
|---|---|---|---|
| 01 | N-terminal region | 5 Residues: Ser49, 52, 68 and Thr150, 172) | 3 Residues: Ser54, 59, 191 |
| 02 | POUs POUs domain | Nil | Nil |
| 03 | POUh domain | Nil | 2 Residues: Ser301, 323 |
| 04 | Linker region of POUs & POUh | 1 Residue: Ser271 | 2 Residues: Ser274, 284 |
| 05 | C-terminal region | 6 Residues: Ser371, 389, 435, 441, 448, 452 | 1 Residues: Ser394 |
Figure 4The phylogenetic tree generated by CLUSTALW with all sequences for mammalian, catfish and Drosophila Oct-2.
Figure 5Sequence logos for different aligned regions of Oct-2. The conserved S/T residues with modification potential and with experimental evidence for modification in the region they are located are marked by a blue asterisk on the top of these residues. Whereas other conserved Ser residues are marked by red asterisk, which display either high or low potential as Yin Yang sites but lacking experimental evidence for modification in the region where they are located.